Professor Prasanna Sooriakumaran will discuss ‘The PRESIDENT trial- an HTA-funded multi-centre UK full randomised controlled trial of surgery plus current best care versus current best care alone in men diagnosed with low volume metastatic hormone sensitive prostate cancer using novel molecular imaging with PSMA PET/CT.’

Prasanna Sooriakumaran, known as PS, is a Consultant Urologist at University College London Hospitals NHS Foundation Trust where he performs the unit’s largest volume of complex and salvage robotic prostatectomy surgery. He holds visiting professorships in urology at Oxford and the All-India Institute of Medical Sciences and is also the Clinical Lead for Robotic Soft-Tissue Surgery at the National Institute for Health and Care Excellence (NICE). He has been interested in the topic of surgery for metastatic prostate cancer for over a decade and has conducted many observational studies as well as the world’s first feasibility randomised controlled trial (RCT) in the field. He has recently been funded by the HTA as the Chief Investigator on a multi-centre full UK-wide RCT of surgery in metastatic prostate cancer.

The Chief Medical Officer has confirmed that attendance at the Surgical Grand Rounds can count toward internal CPD, with 1 point awarded per hour. Please note that in-person attendance is required, and you will need to sign the attendance register.

All members of the University and NHS clinical staff are welcome.

Please email Tarryn Ching if you would like to attend online.